Daniel Shoskes, MD

216.444.5600

Daniel Shoskes, MD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.4757
WorkFax:216.444.0390
Daniel Shoskes, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.4757
WorkFax:216.444.0390
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Daniel A. Shoskes, MD, MSc, FRCS(C), is an Attending Urologist at the Glickman Urological and Kidney Institute at Cleveland Clinic's main campus. Dr. Shoskes' specialty interests are renal transplantation, chronic prostatitis, chronic pelvic pain syndrome, interstitial cystitis, benign prostatic hypertrophy, erectile dysfunction and low testosterone in the aging male. He is also Professor of Surgery, Cleveland Lerner College of Medicine, Case Western Reserve University.

Dr. Shoskes earned his medical degree from the University of Toronto Faculty of Medicine in 1985; he had previously completed his undergraduate studies at the University of Toronto, graduating in 1981. He served a comprehensive surgery internship at Toronto's Wellesley Hospital and a residency in urology at the University of Toronto. He was a Research Fellow at the University of Alberta in 1988 and 1989, where he earned an MSc in experimental surgery. Dr. Shoskes also served a research fellowship at the Nuffield Department of Surgery, Oxford, England, and was a Fellow in renal transplantation and renovascular surgery at Cleveland Clinic.

He held academic positions at the University of Oxford, where he was a Clinical Lecturer in surgery; at the University of California, Los Angeles, as an Assistant and then Associate Professor in the Department of Urology; as Vice Chairman of the Regional Organ Procurement Agency in Los Angeles; and at Nova Southeastern University, Fort Lauderdale, Fla. While in Florida, he was also Chairman of the Department of Renal Transplantation at Cleveland Clinic Florida. He joined the Staff of Cleveland Clinic in Ohio in 2005.

Dr. Shoskes has received a number of research grants, published numerous articles and is a frequent presenter. He is board-certified in urology from the Royal College of Physicians and Surgeons of Canada.

Professional Highlights

Director, American Urological Association Board Review Course

Education & Fellowships

Fellowship - Cleveland Clinic
Renal Transplantation
Cleveland, OH USA
1994
Fellowship - Nuffield Institute of Surgery
Research
Oxford England, United Kingdom
1993
Residency - The Toronto Hospital
Urology
Toronto, Ontario Canada
1991
Internship - Wellesley Hospital
Surgery
Toronto, Ontario, CN Canada
1986
Medical School - University of Toronto Faculty of Medicine
Toronto Canada
1985

Certifications

  • Royal College of Physicians & Surgeons of Canada- Urology

Specialty Interests

BPH, Chronic pelvic pain syndrome, chronic prostatitis, interstitial cystitis, kidney (renal) transplantation, male hypogonadism, erectile dysfunction

Awards & Honors

  • National Institute of Health funding for prostatitis research

Innovations & Patents

  • Pioneered the use of bioflavonoids for therapy of chronic prostatitis/chronic pelvic pain syndrome
  • Developed the UPOINT system to classify patient with pelvic pain into clinically relevant phenotypes and direct therapy

Memberships

  • Past President, Society for Infection and Inflammation in Urology
  • Past President, Urologic Society for Transplantation and Renal Surgery
  • Program committee and Prize Essay committee, American Urological Association
  • American Society of Transplant Surgeons
  • The Transplantation Society

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/9/2013, Dr. Shoskes has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Shoskes received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Farr Laboratories, LLC.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site